PROFESSIONAL EDITION

The largest community of pharma leaders

Xentria Announces FDA Orphan Drug Designation for XTMAB-16 in Sarcoidosis

CHICAGO–(BUSINESS WIRE)–Xentria Announces FDA Orphan Drug Designation for XTMAB-16 in Sarcoidosis

Source Business Wire Health: Pharmaceutical NewsRead More

Recent Articles